Codexis Operating Margin from 2010 to 2024
| CDXS Stock | USD 4.33 0.08 1.88% |
Check Codexis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Codexis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.9 M, Interest Expense of 1.9 M or Selling General Administrative of 35.1 M, as well as many indicators such as Price To Sales Ratio of 4.5, Dividend Yield of 0.0 or PTB Ratio of 4.05. Codexis financial statements analysis is a perfect complement when working with Codexis Valuation or Volatility modules.
Codexis | Operating Margin |
Latest Codexis' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Codexis over the last few years. It is Codexis' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Codexis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.29) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Codexis Operating Margin Regression Statistics
| Arithmetic Mean | (0.52) | |
| Coefficient Of Variation | (87.85) | |
| Mean Deviation | 0.36 | |
| Median | (0.35) | |
| Standard Deviation | 0.45 | |
| Sample Variance | 0.20 | |
| Range | 1.4232 | |
| R-Value | 0.17 | |
| Mean Square Error | 0.21 | |
| R-Squared | 0.03 | |
| Significance | 0.54 | |
| Slope | 0.02 | |
| Total Sum of Squares | 2.87 |
Codexis Operating Margin History
About Codexis Financial Statements
Codexis shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Codexis investors may analyze each financial statement separately, they are all interrelated. The changes in Codexis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Codexis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.